Observational, Long-term Safety and Tolerability Study (LLSAT) of Linerixibat in Adults with PBC and moderate to severe itch
admin
Wednesday, September 25, 2024 - 13:37
OBSErve-LN: Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With Lupus Nephritis (LN)
ben
Friday, October 24, 2025 - 13:16
OBSErve-LN: Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With Lupus Nephritis (LN)
ben
Friday, October 31, 2025 - 21:19
OCEAN: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
roman
Wednesday, October 1, 2025 - 20:28
OCEAN: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
roman
Wednesday, October 15, 2025 - 01:05
OCEAN: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
roman
Sunday, October 26, 2025 - 00:53
OCEAN: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
roman
Friday, October 31, 2025 - 21:22
OCEAN: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
roman
Thursday, October 30, 2025 - 17:00